Loading…
Syngenta agreed to settle lawsuits brought by U.S. corn farmers who claimed it negligently commercialized the Viptera GMO corn seed before China approved it. The article notes that Chinese authorities had rejected millions of tonnes of U.S. corn imports before approving Viptera in December 2014.
The settlement removes litigation risk around GMO corn commercialization but has little direct effect on prices. It is a reminder that biotech approval gaps can disrupt corn export flows to China.
reuters.comNate RaymondSep 26, 2017After 480 past neutral trade events, Corn moved a median +0.2% over 5 sessions (54% higher; middle half -1.1% to +1.6%), and +0.7% over 20.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
